Arterial Compliance in Permanent Essential Hypertension: Preliminary Report
- Time to Diagnosis of Pulmonary Arterial Hypertension. Brown, Lynette M.; Elliott, C. Gregory // Advances in Pulmonary Hypertension;Summer2012, Vol. 11 Issue 2, p69
The article discusses the issues behind the delayed in the diagnosis of pulmonary arterial hypertension (PAH). It notes that patient with PAH are usually symptomatic for years prior to receiving an accurate diagnosis. It talks about the role of patients, as well as the physicians, in the delayed...
- Training for skeletal muscle capillarization: a Janus-faced role of exercise intensity? Gliemann, Lasse // European Journal of Applied Physiology;Aug2016, Vol. 116 Issue 8, p1443
An introduction is presented which discusses various reports published within the issue on topics including exercise pulmonary hypertension, blood circulation disorders and cardiovascular diseases.
- Re: Pulmonary arterial hypertension in connective tissue diseasesâ€”Reply. SMITH, V.; DE PAUW, M.; BRUSSELLE, G.; VAN PRAET, J.; DE KEYSER, F. // Rheumatology;Sep2007, Vol. 46 Issue 9, p1510
A letter to the editor is presented in response to comments on a study concerning pulmonary arterial hypertension.
- Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Yigla, Mordechai; Fruchter, Oren; Aharonson, Doron; Yanay, Noa; Reisner, Shimon A.; Lewin, Moshe; Nakhoul, Farid // Kidney International;May2009, Vol. 75 Issue 9, p969
Pulmonary hypertension in patients with end-stage renal disease on hemodialysis is a newly described entity. To determine its impact, we measured selected clinical variables in the survival of 127 hemodialysis patients. Overall, pulmonary hypertension was found in 37 of these patients; it was...
- Ambrisentan. Newman, John H.; Kar, Santwana; Kirkpatrick, Peter // Nature Reviews Drug Discovery;Sep2007, Vol. 6 Issue 9, p697
Ambrisentan (Letairis; Gilead), a selective endothelin type A receptor antagonist, was approved by the US FDA for the treatment of pulmonary arterial hypertension in June 2007.
- Portopulmonary Hypertension in Patients Undergoing Liver Transplantation: A Case Report. Shimozono, Emica; Caruy, Cristina A. A.; Cardoso, Adilson R.; Boin, Ilka F. S. F. // Surgical Science;Feb2014, Vol. 5 Issue 2, p53
Portopulmonary hypertension (PPH) is a form of pulmonary arterial hypertension, characterized by elevation of pulmonary arterial pressure due to increased resistance to pulmonary blood flow. It is a consequence of portal hypertension, associated or not with liver disease. A retrospective study...
- Living-related lobar transplantation and simultaneous atrial septal defect closure in a young patient with irreversible pulmonary hypertension: a case report. Matsuda, Hikaru; Minami, Masato; Ichikawa, Hajime; Fukushima, Norihide; Ohta, Mitsunori; Saito, Mikiko; Kita, Tomoko; Matsushita, Toru // Heart & Vessels;Jul2004, Vol. 19 Issue 4, p203
A 6-year-old boy was diagnosed as having atrial septal defect with oversystemic pulmonary hypertension, and gradually developed hypoxia and heart failure. At the age of 11, living-related bilateral lobar lung transplantation from his parents was indicated, because of his critical condition. The...
- Evaluation and Management of the Patient with Pulmonary Arterial Hypertension. Rubin, Lewis J.; Badesch, David B. // Annals of Internal Medicine;8/16/2005, Vol. 143 Issue 4, p282
Increased pressure in the pulmonary circulation, or pulmonary hypertension, is a common disorder that may complicate various cardiopulmonary conditions, including severe obstructive airways disease and left ventricular dysfunction. An increase in pulmonary arterial pressure that is not due to...
- Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. Kind, Taco; Mauritz, Gert-Jan; Marcus, J. Tim; van de Veerdonk, Mariëlle; Westerhof, Nico; Vonk-Noordegraaf, Anton // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2010, Vol. 12, p35
Background: Longitudinal wall motion of the right ventricle (RV), generally quantified as tricuspid annular systolic excursion (TAPSE), has been well studied in pulmonary hypertension (PH). In contrast, transverse wall motion has been examined less. Therefore, the aim of this study was to...